Cargando…

Metabolic effects of dopamine agonists in patients with prolactinomas: a systematic review and meta-analysis

OBJECTIVES: Recent large cohort studies suggest an association between high plasma prolactin and cardiovascular mortality. The objective of this systematic review was to systematically assess the effect of reducing prolactin with dopamine agonist on established cardiovascular risk factors in patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Byberg, Sarah, Futtrup, Jesper, Andreassen, Mikkel, Krogh, Jesper
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826167/ https://www.ncbi.nlm.nih.gov/pubmed/31518995 http://dx.doi.org/10.1530/EC-19-0286

Ejemplares similares

The recurrence of prolactinoma after withdrawal of dopamine agonist: a systematic review and meta-analysis
por: Zou, Yunzhi, et al.
Publicado: (2021)

The Mechanism and Pathways of Dopamine and Dopamine Agonists in Prolactinomas
por: Liu, Xiaoshuang, et al.
Publicado: (2019)

Experience with Dopamine Agonists in the Treatment of Prolactinomas
por: Barabash, Nadiya Ye., et al.
Publicado: (2022)

Effect of Tamoxifen on the Management of Dopamine Agonist-Resistant Prolactinomas: A Systematic Review
por: Bazuhair, Tuqa, et al.
Publicado: (2023)

Predictors of dopamine agonist resistance in prolactinoma patients
por: Vermeulen, Elle, et al.
Publicado: (2020)

Are dopamine agonists still the first-choice treatment for prolactinoma in the era of endoscopy? A systematic review and meta-analysis
por: Cai, Xiangming, et al.
Publicado: (2022)

Dopamine agonist therapy for prolactinomas: do we need to rethink the place of surgery in prolactinoma management?
por: De Sousa, Sunita M C
Publicado: (2022)

Blood-brain barrier pathology in patients with severe mental disorders: a systematic review and meta-analysis of biomarkers in case-control studies
por: Futtrup, Jesper, et al.
Publicado: (2020)

Pituitary surgery for small prolactinomas as an alternative to treatment with dopamine agonists
por: Babey, Muriel, et al.
Publicado: (2010)

Dopamine agonist resistant prolactinomas: any alternative medical treatment?
por: Souteiro, P., et al.
Publicado: (2019)

Case Report: Temozolomide Treatment of Refractory Prolactinoma Resistant to Dopamine Agonists
por: Tang, Hao, et al.
Publicado: (2021)

Long-term Outcome of Microscopic Transsphenoidal Surgery for Prolactinomas as an Alternative to Dopamine Agonists
por: Park, Kawngwoo, et al.
Publicado: (2021)

PMON169 D2R Expression in Dopamine-Agonist Resistant Prolactinomas
por: Levine, Alice, et al.
Publicado: (2022)

Successful Improvement of Metabolic Disorders, Including Osteopenia, by a Dopamine Agonist in a Male Patient with Macro-Prolactinoma
por: Takeno, Ayumu, et al.
Publicado: (2016)

Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas
por: Gao, Hua, et al.
Publicado: (2015)

Prolactinomas Resistant to Treatment With Dopamine Agonists: Long-Term Follow-Up of Six Cases
por: Gonzaga, Maria de Fátima de Magalhães, et al.
Publicado: (2018)

SUN-448 Giant Prolactinomas: A Follow-Up of 25 Years with Dopamine Agonists
por: Mallea Gil, Susana, et al.
Publicado: (2019)

Change in Insulin Sensitivity and Lipid Profile After Dopamine Agonist Therapy in Patients With Prolactinoma
por: Khalil, Ghayyur, et al.
Publicado: (2021)

Morbid Obesity Due to Prolactinoma and Significant Weight Loss After Dopamine Agonist Treatment
por: Ali, Muzaffar, et al.
Publicado: (2021)

Pituitary Prolactinoma with Amyloid Deposits: Surgery or Dopamine Agonists? Review of Previous Reports and New Recommendations for Management
por: Prabhu, Santosh, et al.
Publicado: (2019)

The side effects of dopamine receptor agonist drugs in Chinese prolactinoma patients: a cross sectional study
por: Ke, Xiaoan, et al.
Publicado: (2022)

Status epilepticus induced by treatment with dopamine agonist therapy for giant prolactinoma: a case report
por: Koguchi, Motofumi, et al.
Publicado: (2019)

SAT-247 Use of Double Dopamine Agonists in Giant Prolactinomas: A Series of 6 Cases
por: Kuan, Yueh Chien
Publicado: (2020)

MON-293 The Prevalence of Impulse Control Disorders in Patients with Acromegaly and Prolactinomas Treated with Dopamine Agonists
por: Ozkaya, Hande Mefkure, et al.
Publicado: (2020)

FRI303 PRL-R Variants Are Not Only Associated With Prolactinomas But Also With Dopamine Agonist Resistance
por: de Castro Moreira, Andrea Ramos, et al.
Publicado: (2023)

Delayed presentation of late-onset cerebrospinal fluid rhinorrhoea following dopamine agonist therapy for giant prolactinoma
por: Prague, J K, et al.
Publicado: (2014)

PMON78 Improvement in Resistant Hypogonadism with use of Clomiphene in Prolactinomas Treated with Dopamine Agonist: A Case Study and Review of Literature
por: Singh, Julie, et al.
Publicado: (2022)

The role of MAPK11/12/13/14 (p38 MAPK) protein in dopamine agonist-resistant prolactinomas
por: Wang, Shuman, et al.
Publicado: (2021)

FRI305 Impulse Control Disorders In Patients With Prolactinomas And Non-Functioning Pituitary Adenomas Treated With Dopamine Agonists
por: Kolitz, Tamara, et al.
Publicado: (2023)

SAT-455 Analysis of a Group of Prolactinomas Resistant to Treatment with Dopamine Agonists at a University Hospital in Buenos Aires, Argentina
por: Gonzalez Pernas, Mariana, et al.
Publicado: (2019)

FRI300 Prolactinoma And Pregnancy: A Systematic Review And Meta-analysis
por: Bandeira, Diego Barata, et al.
Publicado: (2023)

Variation in serum adrenal hormones in female 21-hydroxylase deficient patients
por: Sørensen, Ditte Sofie Dahl, et al.
Publicado: (2022)

Is prolactin receptor signaling a target in dopamine-resistant prolactinomas?
por: Ferraris, Jimena
Publicado: (2023)

Editorial: The metabolic effect of prolactin
por: Krogh, Jesper
Publicado: (2023)

Metabolic effects of prolactin and the role of dopamine agonists: A review
por: Kirsch, Polly, et al.
Publicado: (2022)

Exercise for patients with major depression: a protocol for a systematic review with meta-analysis and trial sequential analysis
por: Krogh, Jesper, et al.
Publicado: (2015)

Exercise for patients with major depression: a systematic review with meta-analysis and trial sequential analysis
por: Krogh, Jesper, et al.
Publicado: (2017)

Preoperative heart rate variability as a predictor of perioperative outcomes: a systematic review without meta-analysis
por: Frandsen, Mikkel Nicklas, et al.
Publicado: (2022)

Expression of Stem Cell Markers and Dopamine D2 Receptors in Human and Rat Prolactinomas
por: Gao, Zhichao, et al.
Publicado: (2017)

SAT620 Dopamine Challenge: Treatment Of Pituitary Macroadenoma/Prolactinoma In Patient On Antipsychotic Medication
por: Bazhenov, Aleksei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_42hfqoto00qhp201sr1ovvcbl8